Teitur Trophics is a Danish biotech company, with a mission to develop innovative treatments for neurodegenerative diseases. Founded in 2020, the company's name, "Teitur," is derived from Old Norse for happiness, reflecting their commitment to improving the lives of those affected by neurodegenerative conditions. Specializing in the biotechnology sector, Teitur Trophics recently secured a significant €28.00M Series A investment on 14 March 2023. The investors in this round included Industrifonden, Sunstone Capital, Innovestor, Sound Bioventures, and p53.
Teitur Trophics
Teitur Trophics is a danish biotech company, developing novel treatments for neurodegenerative diseases.
Founded 2020
Denmark
20 employees
Series A
Total: $28.00M
Biotechnology, Life Sciences
Denmark
20 employees
Series A
Total: $28.00M
Biotechnology, Life Sciences
General Information
Get notified when Teitur Trophics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Teitur Trophics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Denmark Market
Biotechnology
About Teitur Trophics
Taxonomy: biotech, neurodegenerative diseases, treatment development, therapeutics, medical research, drug development
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | •••••• | 5 |
|
14 Mar 2023 |
Teitur Trophics Alternatives & Competitors
Teitur Trophics vs
Neurotrope Inc.
United States
Developing a new approach to combating Alzheimer's disease and other neurodegenerative diseases.
Series A
3 employees
Biotechnology, Health Care
Teitur Trophics vs
Immungenetics AG is a clinical-stage biopharmaceutical company, developing effective treatments for...
4 employees
Biotechnology
Teitur Trophics vs
Nevrargenics Ltd.
United Kingdom
Developing novel medicines for ALS, FTD, Parkinson’s, Alzheimer’s and other neurodegenerative diseas...
6 employees
FAQ About Teitur Trophics
Teitur Trophics is a danish biotech company, developing novel treatments for neurodegenerative diseases.
Teitur Trophics was founded in 2020.
Teitur Trophics is headquartered in Denmark.
Teitur Trophics operates in the following industries: Biotechnology, Life Sciences.
Teitur Trophics has approximately 20 employees.
Teitur Trophics has completed 1 funding round, raising a total of $28.00M. The latest funding stage is Series A.
Top alternatives and competitors to Teitur Trophics include Neurotrope Inc., Immungenetics AG, Nevrargenics Ltd., GeNeuro SA, Lysosomal Therapeutics Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Teitur Trophics and Neurotrope Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Teitur Trophics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.